RxDoctor Payments DataLook up a doctor →

Christopher Harrod, MD

Orthopaedic Surgery · Baton Rouge, LANPI 1285760694

Payments from drug & device makers

$3,133,880in general payments, 2019–2025

Across 257 payments — averaging $12,194 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1.5M
  • East Louisiana Surgical Services, LLC$420K
  • Curiteva, Inc.$326K
  • Innovasis Inc$312K
  • VB Spine LLC$197K
  • Integrity Implants Inc.$160K
  • plus $258K from 26 others
$47,815in research payments, 2019–2025

Across 8 payments — averaging $5976.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bioventus LLC$29K
  • Stryker$19K

What the payments were for

  • Royalty or licence$2,364,92378%
  • Consulting fees$218,2017%
  • Travel & lodging$19,1401%
  • Food & beverage$6,4470%
  • Entertainment$3430%
  • Ownership interest$420,00014%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,133,880 in reported general payments places this provider in the 95th percentile of 286 orthopaedic surgery providers in Louisiana.

See all orthopaedic surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$675,707
Medicare patients
429
Services billed
2,353

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Piroxicam21$11,077
Calcipotriene25$7,217
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen398$3,806
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen417$3,326
Methocarbamol181$966
Baclofen164$689
Gabapentin112$624
Nabumetone12$593
Methylprednisolone93$529
Acetaminophen-CodeineAcetaminophen With Codeine59$419
Chlorzoxazone15$382
Meloxicam125$352
Tramadol Hcl160$330
Tizanidine Hcl43$273
Cyclobenzaprine Hcl32$134

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Baton Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →